K. Hofheinz's Profile

Role	Title	Level	Year	L/R
🐜	Molecular enzymology of lipoxygenases. 7 auth. I. Ivanov, D. Heydeck, K. Hofheinz, Jana Roffeis, V. O’Donnell, H. Kuhn, ... M. Walther	8	2010	8 🐜
🐬	The double-edged role of 12/15-lipoxygenase during inflammation and immunity. Jochen A. Ackermann, K. Hofheinz, M. Zaiss, G. Krönke	6	2017	6 🐬
🐬	The N-terminal β-barrel domain of mammalian lipoxygenases including mouse 5-lipoxygenase is not essential for catalytic activity and membrane binding but exhibits regulatory functions. M. Walther, K. Hofheinz, R. Vogel, Jana Roffeis, H. Kühn	5	2011	5 🐬
🐜	Stereocontrol of Arachidonic Acid Oxygenation by Vertebrate Lipoxygenases 8 auth. Christian Jansen, K. Hofheinz, R. Vogel, Jana Roffeis, M. Anton, P. Reddanna, ... H. Kuhn, M. Walther	5	2011	5 🐜
🦁	Conversion of pro-inflammatory murine Alox5 into an anti-inflammatory 15S-lipoxygenating enzyme by multiple mutations of sequence determinants. 8 auth. K. Hofheinz, K. R. Kakularam, Susan Adel, M. Anton, Aparoy Polymarasetty, P. Reddanna, ... H. Kuhn, Thomas Horn	4	2013	4 🦁
🦁	Adult onset Still's disease associated with malignancy-Cause or coincidence? K. Hofheinz, G. Schett, B. Manger	4	2016	4 🦁
🐬	Phosphorylation mimicking mutations of ALOX5 orthologs of different vertebrates do not alter reaction specificities of the enzymes. Susan Adel, K. Hofheinz, D. Heydeck, H. Kuhn, Ann-Kathrin Häfner	3	2014	3 🐬
🦁	Formation of atherosclerotic lesions is independent of eosinophils in male mice. 10 auth. K. Hofheinz, Fabian Seibert, Jochen A. Ackermann, B. Dietel, M. Tauchi, M. Oszvar-Kozma, ... H. Kühn, G. Schett, C. Binder, G. Krönke	2	2020	2 🦁
🐬	AB0712 Eligibility of patients with giant cell arteritis for entry into a prospective randomised controlled trial: a single-centre experience W. A. Schmidt, K. Hofheinz, S. Burger, V.S. Schäfer, A. Juche	1	2018	1 🐬